<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="int-interactant" /><meta name="keywords" content="" /><title>Aminophylline: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="41001i735.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="41001i735.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=41001i735.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="41001.htm">Appendix 1 Interactions</a> &gt; <a href="53178.htm">List of drug interactions</a> &gt; <a href="41001i734.htm">Theophylline</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="41001i734.htm" title="Previous: Theophylline">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="41001i935.htm" title="Next: Thyroid Hormones">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_41001i735">Aminophylline</h1><div id="pC" class="jN"><p class="int-specific-drug-name"><b>Aminophylline</b>
          has no specific interaction information.
        </p><p>Aminophylline belongs to <b>Theophylline</b>
          and will have the following interactions:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody>













































<tr><td><a href="41001i551.htm">Acetazolamide</a></td><td>increased risk of hypokalaemia when  theophylline given with acetazolamide </td><td></td></tr><tr><td><a href="41001i392.htm">Aciclovir</a></td><td>plasma concentration of  theophylline possibly increased by aciclovir </td><td>Interactions do not apply to topical aciclovir preparations</td></tr><tr><td><a href="41001i117.htm">Adenosine</a></td><td> theophylline antagonises anti-arrhythmic effect of adenosine </td><td>Possibility of interaction with drugs tending to impair myocardial conduction</td></tr><tr><td><a href="41001i22.htm">Allopurinol</a></td><td>plasma concentration of  theophylline possibly increased by allopurinol </td><td></td></tr><tr><td><a href="41001i405.htm">Benzodiazepines</a></td><td> theophylline possibly reduces effects of benzodiazepines </td><td></td></tr><tr><td><a href="41001i466.htm">Calcium-channel Blockers</a></td><td class="cBV"><b>plasma concentration of  theophylline possibly increased by calcium-channel blockers (enhanced effect)</b></td><td>Dihydropyridine calcium-channel blockers include amlodipine, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine, and nimodipine</td></tr><tr><td><a href="41001i277.htm">Carbamazepine</a></td><td>metabolism of  theophylline accelerated by carbamazepine (reduced effect)</td><td></td></tr><tr><td><a href="41001i744.htm">Cimetidine</a></td><td class="cBV"><b>metabolism of  theophylline inhibited by cimetidine (increased plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i195.htm">Ciprofloxacin</a></td><td class="cBV"><b>plasma concentration of  theophylline increased by ciprofloxacin </b></td><td></td></tr><tr><td><a href="41001i168.htm">Clarithromycin</a></td><td>plasma concentration of  theophylline possibly increased by clarithromycin </td><td></td></tr><tr><td><a href="41001i484.htm">Corticosteroids</a></td><td>increased risk of hypokalaemia when  theophylline given with corticosteroids </td><td>Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</td></tr><tr><td><a href="41001i468.htm">Diltiazem</a></td><td>plasma concentration of  theophylline increased by diltiazem </td><td></td></tr><tr><td><a href="41001i523.htm">Disulfiram</a></td><td>metabolism of  theophylline inhibited by disulfiram (increased risk of toxicity)</td><td></td></tr><tr><td><a href="41001i539.htm">Diuretics, Loop</a></td><td>increased risk of hypokalaemia when  theophylline given with loop diuretics </td><td></td></tr><tr><td><a href="41001i525.htm">Diuretics, Thiazide and related</a></td><td>increased risk of hypokalaemia when  theophylline given with thiazides and related diuretics </td><td></td></tr><tr><td><a href="41001i561.htm">Doxapram</a></td><td>increased CNS stimulation when  theophylline given with doxapram </td><td></td></tr><tr><td><a href="41001i708.htm">Ephedrine</a></td><td>manufacturer of  theophylline advises avoid concomitant use with ephedrine in children</td><td></td></tr><tr><td><a href="41001i169.htm">Erythromycin</a></td><td class="cBV"><b>plasma concentration of  theophylline increased by erythromycin (also theophylline may reduce absorption of <i>oral</i> erythromycin)</b></td><td>Interactions do not apply to small amounts of erythromycin used topically</td></tr><tr><td><a href="41001i1178.htm">Febuxostat</a></td><td class="cBV"><b>caution with  theophylline advised by manufacturer of febuxostat </b></td><td></td></tr><tr><td><a href="41001i301.htm">Fluconazole</a></td><td class="cBV"><b>plasma concentration of  theophylline possibly increased by fluconazole </b></td><td>In general, fluconazole interactions relate to multiple-dose treatment</td></tr><tr><td><a href="41001i235.htm">Fluvoxamine</a></td><td class="cBV"><b>plasma concentration of  theophylline increased by fluvoxamine (concomitant use should usually be avoided, but where not possible halve theophylline dose and monitor plasma-theophylline concentration)</b></td><td></td></tr><tr><td><a href="41001i1100.htm">Halothane</a></td><td>increased risk of arrhythmias when  theophylline given with halothane </td><td></td></tr><tr><td><a href="41001i758.htm">Influenza Vaccine</a></td><td>plasma concentration of  theophylline possibly increased by influenza vaccine </td><td></td></tr><tr><td><a href="41001i586.htm">Interferon Alfa</a></td><td class="cBV"><b>metabolism of  theophylline inhibited by interferon alfa (consider reducing dose of theophylline)</b></td><td></td></tr><tr><td><a href="41001i165.htm">Isoniazid</a></td><td>plasma concentration of  theophylline possibly increased by isoniazid </td><td></td></tr><tr><td><a href="41001i45.htm">Ketamine</a></td><td>increased risk of convulsions when  theophylline given with ketamine </td><td></td></tr><tr><td><a href="41001i298.htm">Ketoconazole</a></td><td class="cBV"><b>plasma concentration of  theophylline possibly increased by ketoconazole </b></td><td></td></tr><tr><td><a href="41001i372.htm">Lithium</a></td><td> theophylline increases excretion of lithium (reduced plasma concentration)</td><td></td></tr><tr><td><a href="41001i511.htm">Methotrexate</a></td><td>plasma concentration of  theophylline possibly increased by methotrexate </td><td></td></tr><tr><td><a href="41001i197.htm">Norfloxacin</a></td><td class="cBV"><b>plasma concentration of  theophylline increased by norfloxacin </b></td><td></td></tr><tr><td><a href="41001i636.htm">Oestrogens</a></td><td>plasma concentration of  theophylline increased by oestrogens (consider reducing dose of theophylline)</td><td>Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="4552.htm#_120026">section 7.3.1</a></td></tr><tr><td><a href="41001i826.htm">Pentoxifylline</a></td><td>plasma concentration of  theophylline increased by pentoxifylline </td><td></td></tr><tr><td><a href="41001i437.htm">Phenobarbital</a></td><td class="cBV"><b>metabolism of  theophylline accelerated by phenobarbital (reduced effect)</b></td><td></td></tr><tr><td><a href="41001i284.htm">Phenytoin</a></td><td class="cBV"><b>plasma concentration of both drugs reduced when  theophylline given with phenytoin </b></td><td></td></tr><tr><td><a href="41001i125.htm">Propafenone</a></td><td>plasma concentration of  theophylline increased by propafenone </td><td></td></tr><tr><td><a href="41001i193.htm">Quinolones</a></td><td class="cBV"><b>possible increased risk of convulsions when  theophylline given with quinolones </b></td><td></td></tr><tr><td><a href="41001i201.htm">Rifampicin</a></td><td>metabolism of  theophylline accelerated by rifampicin (reduced plasma concentration)</td><td></td></tr><tr><td><a href="41001i400.htm">Ritonavir</a></td><td class="cBV"><b>metabolism of  theophylline accelerated by ritonavir (reduced plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i1190.htm">Roflumilast</a></td><td>avoidance of  theophylline advised by manufacturer of roflumilast </td><td></td></tr><tr><td><a href="41001i905.htm">St John's Wort</a></td><td class="cBV"><b>plasma concentration of  theophylline reduced by St John's wort—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i755.htm">Sucralfate</a></td><td>absorption of   theophylline possibly reduced by sucralfate (give at least 2 hours apart)</td><td></td></tr><tr><td><a href="41001i689.htm">Sulfinpyrazone</a></td><td>plasma concentration of  theophylline reduced by sulfinpyrazone </td><td></td></tr><tr><td><a href="41001i720.htm">Sympathomimetics, Beta<sub>2</sub></a></td><td>increased risk of hypokalaemia when  theophylline given with high doses of beta<sub>2</sub> sympathomimetics—see Hypokalaemia, <a title="CSM hypokalaemia (target-block)" href="2878.htm#_2878.8">section 3.1.1.1</a></td><td></td></tr><tr><td><a href="41001i467.htm">Verapamil</a></td><td class="cBV"><b>plasma concentration of  theophylline increased by verapamil (enhanced effect)</b></td><td></td></tr><tr><td><a href="41001i859.htm">Zafirlukast</a></td><td>plasma concentration of  theophylline possibly increased by zafirlukast , also plasma concentration of zafirlukast reduced</td><td></td></tr></tbody></table></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="41001i734.htm">Previous: Theophylline</a> | <a class="top" href="41001i735.htm#">Top</a> | <a accesskey="]" href="41001i935.htm">Next: Thyroid Hormones</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>